Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-438277
Filing Date
2013-11-12
Accepted
2013-11-12 16:16:29
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d615468d10q.htm 10-Q 436729
2 EX-31.1 d615468dex311.htm EX-31.1 6568
3 EX-31.2 d615468dex312.htm EX-31.2 6603
4 EX-32.1 d615468dex321.htm EX-32.1 4133
5 EX-32.2 d615468dex322.htm EX-32.2 4139
  Complete submission text file 0001193125-13-438277.txt   3604841

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pbyi-20130930.xml EX-101.INS 405882
7 XBRL TAXONOMY EXTENSION SCHEMA pbyi-20130930.xsd EX-101.SCH 38318
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbyi-20130930_cal.xml EX-101.CAL 45354
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbyi-20130930_def.xml EX-101.DEF 233067
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbyi-20130930_lab.xml EX-101.LAB 336255
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbyi-20130930_pre.xml EX-101.PRE 270874
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

EIN.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35703 | Film No.: 131210362
SIC: 2834 Pharmaceutical Preparations